Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04049799 · ClinicalTrials.gov registry record
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
A clinical trial, sponsored by University of Vermont.
- Completed
- Registry status
- 88
- Enrollment target
NCT04049799 is a clinical trial that has completed, run by University of Vermont. The registered enrollment target is 88 participants.
The verdict
NCT04049799 has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
This study will compare medically-supervised withdrawal (MSW, 'detoxification') to opioid agonist treatment (OAT, 'maintenance') with buprenorphine for pregnant women with opioid use disorder in terms of maternal, fetal, and neonatal outcomes. Outcomes will be assessed during pregnancy, at birth and for 12 months postpartum. This study has the potential to impact health service policy and practices in terms of the treatment options of pregnant women with opioid use disorder.
Interventions
- OTHER Medically-supervised withdrawal
- OTHER Opioid agonist treatment
- BEHAVIORAL Comprehensive clinical care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2019-08-08 |
| Est. Completion | 2024-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04049799
The ClinicalTrials.gov registry entry for NCT04049799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Medically-supervised withdrawal is the first listed.
NCT04049799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04049799 about?
NCT04049799 is a clinical study titled "Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions". This study will compare medically-supervised withdrawal (MSW, 'detoxification') to opioid agonist treatment (OAT, 'maintenance') with buprenorphine for pregnant women with opioid use disorder in terms of maternal, fetal, and neonatal outcomes. Outcomes will be assessed during pregnancy, at birth and...
What is the current status of trial NCT04049799?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2019-08-08. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT04049799?
The interventions under investigation include: Medically-supervised withdrawal (OTHER), Opioid agonist treatment (OTHER), Comprehensive clinical care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04049799?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.